The global Vascular Image Analysis AI Software market size is predicted to grow from US$ 783 million in 2025 to US$ 2134 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.

Vascular image analysis AI software is a specialized software platform integrating medical image processing, computer vision, and machine learning algorithms. Its main functions include: automatically or semi-automatically analyzing vascular systems in medical images (such as CTA, MRA, and ultrasound) to enhance physicians diagnostic capabilities, quantitatively assess vascular lesions, and assist in clinical decision-making. The demand stems from the urgent clinical need to improve the efficiency, accuracy, and standardization of vascular disease diagnosis, particularly in addressing the vast clinical gap in early screening, precise diagnosis, and interventional treatment planning for major chronic diseases such as coronary heart disease, stroke, and aortic diseases. This growth is driven by population aging, the trend towards precision medicine, and the general pressure on healthcare systems to reduce costs and improve efficiency. The upstream supply chain of vascular image analysis AI software relies on high-quality, multi-modal medical image data and accurate annotations, which depend on deep cooperation with large hospitals, medical image databases, and professional medical annotation platforms, as well as support from underlying technology companies providing high-performance AI chips and cloud computing resources. The midstream consists of core technology development and productization, dominated by professional AI medical software companies, the software departments of large imaging equipment manufacturers, and medical IT giants. They transform algorithms into clinical-grade software that passes regulatory approval and can be integrated with hospital information systems. Downstream, the software is deployed through medical device distributors, direct sales, or cloud services to radiology departments, cardiology departments, neurology departments, physical examination centers, and third-party independent imaging centers in hospitals of all levels, assisting physicians in diagnosis, quantitative assessment, and surgical planning. In 2025, the production of vascular image analysis AI software is approximately 10,000 units, with an average selling price of approximately $80,000 per unit and a gross profit margin of approximately 50%.

United States market for Vascular Image Analysis AI Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Vascular Image Analysis AI Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Vascular Image Analysis AI Software is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Vascular Image Analysis AI Software players cover Siemens Healthineers, GE Healthcare, Philips Healthcare, Circle Cardiovascular Imaging, Arterys, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information) newest research report, the ?Vascular Image Analysis AI Software Industry Forecast? looks at past sales and reviews total world Vascular Image Analysis AI Software sales in 2025, providing a comprehensive analysis by region and market sector of projected Vascular Image Analysis AI Software sales for 2026 through 2032. With Vascular Image Analysis AI Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Image Analysis AI Software industry.

This Insight Report provides a comprehensive analysis of the global Vascular Image Analysis AI Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vascular Image Analysis AI Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Vascular Image Analysis AI Software market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Image Analysis AI Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Image Analysis AI Software.

This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Image Analysis AI Software market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Independent Diagnostic Software
    Embedded Post-processing Module
    Cloud Platform Analysis
    Segmentation by Target Vascular System:
    Coronary Artery Analysis
    Cerebral Blood Vessel Analysis
    Retinal Blood Vessel Analysis
    Aorta Analysis
    Hepatic Blood Vessel Analysis
    Tumor Blood Vessel Analysis

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Siemens Healthineers
    GE Healthcare
    Philips Healthcare
    Circle Cardiovascular Imaging
    Arterys
    Mode Technologies
    Cleerly, Inc
    Aidoc
    Elucid
    HeartFlow